Brevan Howard Capital Management LP Merus N.V. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Merus N.V. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 13,639 shares of MRUS stock, worth $558,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,639Holding current value
$558,380% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
62MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$171 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$140 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$137 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$118 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$107 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.88B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...